[Dermatomyositis and polymyositis].
Tanimoto
K
K
Health Service Center, Saitama University.
D000328:Adult; D000367:Age Factors; D000368:Aged; D002648:Child; D003402:Creatine Kinase / Q000097:blood; D003520:Cyclophosphamide / Q000627:therapeutic use; D003882:Dermatomyositis / Q000175:diagnosis* / Q000188:drug therapy; D004576:Electromyography; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D017285:Polymyositis / Q000175:diagnosis* / Q000188:drug therapy; D011379:Prognosis; D012015:Reference Standards; D012737:Sex Factors
D003520:Cyclophosphamide; D003402:Creatine Kinase; D008775:Methylprednisolone; D008727:Methotrexate